Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019-Reference-Cited by-同舟云学术

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019

Published:2019-02-21 Issue:8 Volume:24 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Kissling Esther¹²,Rose Angela¹²,Emborg Hanne-Dorthe³,Gherasim Alin⁴,Pebody Richard⁵,Pozo Francisco⁶,Trebbien Ramona⁷,Mazagatos Clara⁴,Whitaker Heather⁵,Valenciano Marta²,

Affiliation:

1. These authors contributed equally to the study and manuscript writing

2. EpiConcept, Paris, France

3. Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark

4. National Epidemiology Centre, Institute of Health Carlos III, Madrid, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain

5. Public Health England, London, United Kingdom

6. National Centre for Microbiology, National Influenza Reference Laboratory, WHO-National Influenza Centre, Institute of Health Carlos III, Madrid, Spain

7. Department of Virus and Microbiological Special diagnostics, National Influenza Center, Statens Serum Institut, Copenhagen, Denmark

Abstract

Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018–January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32–43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34–38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference19 articles.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe;Vaccine;2024-06

2. Timing of Assessment of Humoral and Cell-Mediated Immunity after Influenza Vaccination;Vaccines;2024-05-27

3. Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines;Human Vaccines & Immunotherapeutics;2024-04-15

4. Safety of applying influenza-antigen-coated microneedles to rat skin and the antigen specific immune response in vivo;Journal of Pharmaceutical Investigation;2024-03-07

5. Age-dependent influenza infection patterns and subtype circulation in Denmark, in seasons 2015/16 to 2021/22;Eurosurveillance;2024-01-25